Clinical Trials on Lymphoplasmacytoid Lymphoma in New Zealand
Total 2034 results
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Mayo Clinic; University of Pennsylvania; University...Active, not recruitingAggressive | B-cell Non-Hodgkin LymphomaUnited States
-
MedImmune LLCTerminatedB-Cell Pediatric ALLUnited States, Australia, France, Spain, Canada, Netherlands, United Kingdom, Italy
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
University of RochesterMillennium Pharmaceuticals, Inc.; CephalonCompletedNon-Hodgkin's LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterSamus TherapeuticsActive, not recruitingNon-Hodgkin's Lymphoma | Myeloma | Active Solid MalignancyUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin LymphomaUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | LeukemiaUnited States
-
SecuraBioTerminatedLymphoma, Small Lymphocytic | Lymphocytic Leukemia, ChronicUnited States, Canada
-
Hoosier Cancer Research NetworkEli Lilly and Company; Walther Cancer InstituteTerminatedLymphoma, B-CellUnited States
-
Icahn School of Medicine at Mount SinaiPfizerRecruiting
-
Acerta Pharma BVAstraZenecaActive, not recruitingMantle Cell Lymphoma (MCL)United States, Poland, Italy
-
Novartis PharmaceuticalsTerminatedDiffuse Large B-Cell LymphomaTaiwan, Netherlands, Hong Kong, Italy, Germany, United States, Spain, France, United Kingdom, Korea, Republic of
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Grade 3 Follicular Lymphoma | Plasmablastic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Primary Effusion Lymphoma | AIDS-Related Primary Effusion Lymphoma | Ann Arbor Stage I Diffuse Large B-Cell Lymphoma | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor... and other conditionsUnited States
-
Rhizen Pharmaceuticals SACompleted
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingAcute Lymphoblastic Leukemia, PediatricUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)The Lymphoma Academic Research OrganisationActive, not recruitingHIV Infection | Ann Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage IIIA Hodgkin Lymphoma | Ann Arbor Stage IIIB Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Ann Arbor Stage IVA Hodgkin Lymphoma | Ann Arbor Stage IVB Hodgkin Lymphoma | Classic Hodgkin Lymphoma | Ann Arbor Stage II Hodgkin... and other conditionsUnited States, France
-
Dynavax Technologies CorporationTerminatedB-cell LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Lymphoblastic Lymphoma | Mixed Phenotype Acute LeukemiaUnited States, Canada, Australia, Puerto Rico, New Zealand
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingFollicular Lymphoma | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell Lymphoma | Mantle-cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedCD79 Mutant or ABC-subtype Diffuse Large B-Cell LymphomaTaiwan, Italy, Netherlands, Hong Kong, Germany, United States, Korea, Republic of, France
-
AmgenCompletedHigh-risk Diffuse Large B-Cell LymphomaUnited States, Canada, Germany, Spain, France, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Down Syndrome | Philadelphia Chromosome Positive | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia | Adult B Lymphoblastic Lymphoma | Ann Arbor Stage I B Lymphoblastic Lymphoma | Ann Arbor Stage... and other conditionsUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
Yale UniversityNational Cancer Institute (NCI)Completed
-
ViaCellCompletedAcute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLC; Celgene CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom, Belgium, Germany
-
Columbia UniversityInternational Agency for Research on CancerRecruitingAcute Lymphoblastic Leukemia | Brain TumorUnited States
-
Karyopharm Therapeutics IncRecruitingDiffuse Large B-cell LymphomaUnited Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Greece, Hungary, India, Israel, Italy, Netherlands, New Zealand, Poland, Serbia, Spain
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia, Bosnia and Herzegovina and more
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedAcute Lymphoblastic LeukemiaUnited States
-
Dartmouth-Hitchcock Medical CenterSpectrum Pharmaceuticals, Inc; CephalonCompletedLymphoma, FollicularUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
-
Hoffmann-La RocheCompletedDiffuse Large B-cell Lymphoma | High-Grade B-cell LymphomaUnited States, Spain, Australia, Denmark
-
Miltenyi Biomedicine GmbHRecruitingCentral Nervous System Lymphoma | Transformed Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL) | Relapsed Diffuse Large B Cell LymphomaUnited States
-
SCRI Development Innovations, LLCAcerta Pharma, LLCCompletedMantle Cell LymphomaUnited States
-
Curis, Inc.The Leukemia and Lymphoma SocietyCompletedLymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditionsUnited States
-
Callisto PharmaceuticalsUnknownAcute Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
MorphoSys AGICON Clinical ResearchActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Hungary, Italy, Poland, Spain, Czechia, Germany, Australia, Austria, Canada, Croatia, Finland, France, Israel, Korea, Republic of, New Zealand, Portugal, Romania, Serbia, Singapore, Taiwan, Turkey, United Kingdom
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedLeukemia | InfectionUnited States
-
MillennixUnknownLymphomaUnited States
-
GlaxoSmithKlineTerminatedNeoplasms | CancerUnited States, United Kingdom, France
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
Prelude TherapeuticsBeiGeneRecruitingT-cell Lymphoma | Mantle Cell Lymphoma (MCL) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Richter's Syndrome | Aggressive B-Cell Non-Hodgkin's Lymphoma | Aggressive B-Cell NHLUnited States, Canada, Korea, Republic of, Australia, France, Poland, Italy, Germany, Switzerland, United Kingdom
-
Weill Medical College of Cornell UniversityM.D. Anderson Cancer Center; Massachusetts General Hospital; Genentech, Inc.CompletedDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingDown Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic LymphomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Piramal Enterprises LimitedTerminatedMantle Cell LymphomaUnited States, India
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.Active, not recruitingPrimary Central Nervous System Lymphoma (PCNSL) | Secondary Central Nervous System Lymphoma (SCNSL)United States
-
Gilead SciencesCompletedNon-Hodgkin's LymphomaUnited States